Dendrobium huoshanense extract as well as extraction method and application thereof
Through the crushing, ethanol extraction and column chromatography of Huoshan Dendrobium, the obtained Huoshan Dendrobium extract DHEE-E75% has a significant inhibitory effect on melanoma cells, solving the problem of insufficient research on the components of Huoshan Dendrobium and realizing the development of Huoshan Dendrobium Effective extraction and anti-tumor activity.
Patent Information
- Application Number
- CN202411071742.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-06
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-08-06
AI Technical Summary
There are few researches on other components in Dendrobium Huoshan except for polysaccharides, especially monomeric compounds, which leads to the in-depth basis of the pharmacological activity of the pharmacological substances, which limits its development and application.
After pulverizing the dried Dendrobium strips of Huoshan, it is heated and extracted in ethanol solution. By ethyl acetate extraction and column chromatography, it can obtain DHEE-E75% of Huoshan Dendrobium extract. The method includes pulverizing the material with 1:10-1:40. The liquid ratio was heated at 70-85°C, followed by ethyl acetate extraction and column chromatography eluting, and concentrated and collected using a 50%-75% ethanol solution.
The extracted DHEE-E75% of Huoshan Dendrobium extracts have a significant inhibitory effect on melanoma cells. In vitro experiments showed that it had a significant inhibitory effect on B16 cell proliferation. In vivo studies showed that it can effectively inhibit tumor growth in mouse melanoma models and There are no toxic side effects in tissues and organs, 390 compounds were detected and 42 components were identified, providing a basis for subsequent screening of anti-tumor active drugs.
Smart Images

Figure CN119015372A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a medicinal material extract, an extraction method and application thereof, and in particular to a Huoshan dendrobium extract, an extraction method and application thereof. Background Art
[0002] Huoshan Dendrobium is a precious Chinese medicinal material. It not only contains active factors such as polysaccharides and flavonoids, but also is rich in various nutrients such as amino acids, vitamins, and proteins. Modern pharmacological studies have shown that it also has a variety of pharmacological activities such as enhancing immunity, lowering blood sugar, and anti-tumor. At present, polysaccharides, one of the main components of Huoshan Dendrobium, have been widely studied, while other components in Huoshan Dendrobium have been studied relatively less, especially monomeric compounds in Huoshan Dendrobium. Therefore, the pharmacological material basis of Huoshan Dendrobium's pharmacological activity needs more in-depth research to promote the development and application of Huoshan Dendrobium. Summary of the invention
[0003] Purpose of the invention: The present invention aims to provide an effective anti-tumor extract of Dendrobium huoshanense; the present invention also aims to provide an extraction method of the Dendrobium huoshanense extract; the present invention also aims to provide an application of the Dendrobium huoshanense extract.
[0004] Technical solution: The method for extracting the Huoshan Dendrobium extract of the present invention comprises:
[0005] Weighing and crushing the dried strips of Dendrobium huoshanense, immersing the crushed Dendrobium huoshanense in an ethanol solution for heating extraction, and obtaining the ethanol extract of Dendrobium huoshanense DHEE;
[0006] The ethanol extract of Dendrobium huoshanense DHEE is extracted with ethyl acetate, and the ethyl acetate phase obtained after the extraction is concentrated under reduced pressure to obtain a DHEE-E component;
[0007] The DHEE-E extract was subjected to column chromatography and eluted with an ethanol solution. The obtained eluate was concentrated under reduced pressure to obtain the Huoshan Dendrobium officinale extract.
[0008] Furthermore, during the heating extraction, the crushed Huoshan Dendrobium is immersed in a 70-80% ethanol solution at a material-liquid ratio of 1:10-1:40 (w:v), the extraction temperature is 70-85°C, and the extraction time is 2-4h.
[0009] Furthermore, the ethyl acetate extraction process includes: taking DHEE freeze-dried powder, fully dissolving it with ethyl acetate, placing it in a separatory funnel, and adding 0.5-2 times the volume of water.
[0010] Furthermore, during column chromatography elution, 8 to 10 column volumes of ethanol solution are used, and the eluate is collected according to 1 to 2 column volumes. The concentration of the ethanol solution used is 50% to 100%, and the more preferred concentration of the ethanol solution is 50% to 75%.
[0011] The Huoshan Dendrobium extract obtained by the above extraction method can be used in the preparation of anti-tumor drugs.
[0012] Furthermore, the tumor is melanoma.
[0013] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages: (1) The water extract of Dendrobium huoshanense obtained by the extraction method has a significant inhibitory effect on melanoma cells; through in vitro experiments such as cell live-death staining and cell morphology, it was found that DHEE-E 75% The results of in vivo studies showed that DHEE-E has the best inhibitory activity on melanoma cells. 75% It can effectively inhibit tumor growth in a mouse melanoma model and has no toxic side effects on various tissues and organs; (2) UPLC-Q-TOF / MS results show that DHEE-E 75% 390 compounds were detected in 75% 42 ingredients were identified. Among them, 26 ingredients such as Isorhamnetin, Isoquercitrin, and Baicalein were DHEE and DHEE-E 75% The common components provide a certain material basis for further screening of anti-tumor active drugs. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] Figure 1 is the UPLC-Q-TOF / MS chromatogram of DHEE;
[0015] Figure 2 for DHEE-E 75% UPLC-Q-TOF / MS chromatogram;
[0016] Figure 3 The effect of DHEE, DHEE-E, DHEE-N and DHEE-U on cell proliferation ( n=3); (A) is the effect of DHEE on the proliferation of B16; (B) is the effect of DHEE-N on the proliferation of B16; (C) is the effect of DHEE-E on the proliferation of B16; (D) is the effect of DHEE-U on the proliferation of B16; as shown in the figure, ns means no significant difference, *P<0.05, **P<0.01, ***P<0.005, ****P<0.0001;
[0017] Figure 4 for DHEE-E U DHEE-E 25% DHEE-E 50% DHEE-E 75% DHEE-E100% Effects on cell proliferation ( n=3); wherein (A) is DHEE-E U Effects on B16 proliferation; (B) DHEE-E 25% Effects on B16 proliferation; (C) DHEE-E 50% Effects on B16 proliferation; (D) DHEE-E 75% Effect on B16 proliferation; (E) DHEE-E 100% Effect on B16 proliferation; as marked in the figure, ns means no significant difference, *P<0.05, **P<0.01, ***P<0.005, ****P<0.0001;
[0018] Figure 5 for DHEE-E U DHEE-E 25% DHEE-E 50% DHEE-E 75% DHEE-E 100% Relative cell proliferation effect ( n=3); (A) is DHEE-E U Effects of DHEE-E on the proliferation of A375 cells; (B) 25% Effects on the proliferation of A375 cells; (C) DHEE-E 50% Effects on the proliferation of A375 cells; (D) DHEE-E 75% Effects on the proliferation of A375 cells; (E) DHEE-E 100% Effects on A375 proliferation; as shown in the figure, ns means no significant difference, *P<0.05, **P<0.01, ***P<0.005, ****P<0.0001;
[0019] Figure 6 for DHEE-E 75% Effects on cell morphology (n=3);
[0020] Figure 7 for DHEE-E 75% Effects on cell live-dead staining (n=3);
[0021] Figure 8 for DHEE-E 75% Effects on B16 cell cycle and apoptosis ( n=3); wherein (A), (B), (C), (D), and (I) are DHEE-E 75%Effects on apoptosis of B16 cells, UL: necrotic cells LL: normal cells UR: late apoptotic cells LR: early apoptotic cells; (E), (F), (G), (H), (J) are DHEE-E 75% Effects on B16 cell cycle; as marked in the figure, *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001;
[0022] Fig. 9 The figure shows the effect of apoptosis protein expression; (A) shows the effect of Bcl-2 and Bax apoptosis protein expression, (B) shows the effect of Bcl-2 apoptosis protein expression, and (C) shows the effect of Bax apoptosis protein expression. n=3); as shown in the figure, *P<0.05, **P<0.01, ***P<0.005, ****P<0.0001;
[0023] Fig.10 for DHEE-E 75% Effects on B16 tumor growth in tumor-bearing mice ( n=5); (A) is the mouse tumor volume ratio diagram; (B) is the weight change of mice after administration; (C) is the mouse tumor weight; (D) is the mouse heart weight ratio diagram; (E) is the mouse spleen weight ratio diagram; (F) is the mouse kidney weight ratio diagram;
[0024] Fig.11 This is a schematic diagram of the process of extracting and separating the active ingredients of Huoshan Dendrobium. DETAILED DESCRIPTION
[0025] The technical solution of the present invention is further described below in conjunction with the accompanying drawings.
[0026] Example
[0027] 1. Extraction and separation of active ingredients
[0028] The specific process is as follows Fig.11 shown.
[0029] Weigh 600 g of dried strips of Dendrobium huoshanense, dry them at 65°C to constant weight, grind them into powder, pass them through a No. 3 sieve, weigh an appropriate amount of crushed medicinal materials, immerse them in 80% ethanol solution at a material-liquid ratio of 1:40 (w:v), extract them in a constant temperature magnetic stirrer at 80°C for 2 h, extract them 3 times, combine the three filtrates, concentrate them under reduced pressure, and evaporate them to dryness at low temperature until there is no alcohol taste, thereby obtaining Dendrobium huoshanense Ethanol Extract (DHEE), and then separate the DHEE by organic solvent extraction, column chromatography and other methods to obtain different components.
[0030] Organic solvent extraction and separation: Separation and preparation of effective components of DHEE. In this experiment, DHEE components were separated according to the principle of immiscibility. Accurately weigh DHEE lyophilized powder, fully dissolve it with ethyl acetate, place it in a separatory funnel, add 0.5 times the volume of water, fully shake, mix evenly, and let it stand until there is a clear dividing line between the two liquid surfaces. Separate the liquid to obtain the DHEE-E component, and repeat the extraction 3 times until the upper layer (organic layer) is colorless. The aqueous phase continues to be extracted with n-butanol (N-Bu), and according to the EAC experimental operation method, DHEE-N component and DHEE-U component are finally obtained. The extracted liquid is concentrated under reduced pressure, diluted with UP, and freeze-dried to obtain a solid powder, which is weighed and the yield is calculated.
[0031] The calculation formula is as follows: C = M1 / M2 × 100%
[0032] Where: C is the yield (%)
[0033] M1 is the weight of the sample after vacuum freeze drying (mg)
[0034] M2 is the weight of the alcohol extract of Dendrobium huoshanense (mg)
[0035] Column chromatography preparation: pre-treatment of macroporous adsorption resin, adding a certain volume of 10% NaCl solution to soak for 6 hours, filtering, adding a certain amount of ethanol to soak for one day, and then wet loading, the column volume is about 900cm 3 , slowly wash the resin with ethanol until there is no white turbid liquid in the effluent, add an appropriate amount of UP for washing until the effluent is clear and has no alcohol taste. Accurately weigh 21.37g of DHEE-E extract, and elute with UP, 25% ethanol, 50% ethanol, 75% ethanol and anhydrous ethanol respectively, eluting for 10 column volumes, collecting the eluate according to 2 column volumes, rotary evaporating in a 50℃ water bath, and marking the original weight of the round-bottom flask, using thin layer spotting until no color is developed, combining the eluates, concentrating under reduced pressure, freeze-drying, and weighing each gradient eluate to obtain DHEE-E U DHEE-E 25% DHEE-E 50% DHEE-E 75% DHEE-E 100% There are 5 components in total.
[0036] 2. LC-MS for DHEE and DHEE-E 75% Component Analysis
[0037] DHEE component analysis: The DHEE extraction rate was 27.65%, of which the DHEE-E fraction yielded 15.26%, the DHEE-N fraction yielded 20.37%, and the DHEE-U fraction yielded 61.46%. UPLC-Q-TOF / MS results showed that 72 components in DHEE were identified. The results are as follows: Figure 1 As shown in Table 1, these compounds are mainly flavonoids, terpenes, amino acids, etc., among which there are 25 flavonoids.
[0038] Table 1 Mass spectrometry information of DHEE chemical components
[0039]
[0040]
[0041]
[0042] DHEE-E 75% Component analysis: Accurately weigh 21.37g of DHEE-E, U The yield of the eluted fraction was 21.67%, DHEE-E 25% The yield of the eluted fraction was 11.75%, DHEE-E 50% The yield of the eluted fraction was 13.52%, and DHEE-E 75% The yield of the eluted fraction was 14.04%, DHEE-E 100% The yield of the eluted components was 28.87%. The UPLC-Q-TOF / MS results showed that DHEE-E 75% 42 components were identified in Figure 2 As shown in Table 2, these compounds are mainly flavonoids, terpenes, amino acids, etc., among which there are 13 flavonoids.
[0043] Table 2 Mass spectrometry information of DHEE-E75% chemical composition
[0044]
[0045]
[0046] 3. Effect of CCK-8 method on the proliferation of B16 cells
[0047] (1) Toxicity experiments of DHEE, DHEE-E, DHEE-N and DHEE-U: According to the results of DHAESM and DHAEM toxicity experiments, DHAESM has a better inhibitory effect on proliferation, and most of the small molecules are flavonoids, alkaloids and other components. Therefore, in subsequent experiments, combined with the experimental platform conditions of this project, DHEE was obtained by alcohol extraction, and three extraction phases of DHEE-E, DHEE-N and DHEE-U were obtained by organic reagent extraction, and the effects of different administration times and dosages of the four components in DHEE, DHEE-E, DHEE-N and DHEE-U on the survival rate of B16 cells were further explored. Figure 3 As shown. Within the concentration range, the administration time is 24h, DHEE, DHEE-E, DHEE-N and DHEE-U all have an inhibitory effect on the proliferation of B16 cells, among which DHEE-E and DHEE have a more obvious inhibitory effect on B16 cells, and DHEE-E has the most obvious effect on B16 cells, with its IC50 = 0.46 ± 0.03 mg / mL, and the cell survival rate decreases with the increase of the administration concentration, and it is dose-dependent. Within the same administration range, the administration time is 48h, DHEE, DHEE-E, DHEE-N and DHEE-U all have an inhibitory effect on the proliferation of B16 cells, among which DHEE-E and DHEE have a more obvious inhibitory effect on B16 cells, and DHEE-E has the most obvious effect on B16 cells, within the administration range of 0.05-0.8 mg / mL, its IC50 = 0.19 ± 0.04 mg / mL, and the cell survival rate decreases with the increase of the administration concentration, and it is dose-dependent.
[0048] (2) DHEE-E U DHEE-E 25% DHEE-E 50% DHEE-E 75% and DHEE-E 100% Toxicity experiment: According to the results of the B16 cell toxicity experiment with different administration times and dosages of the four components of DHEE, DHEE-E, DHEE-N and DHEE-U, DHEE-E has a better effect on the proliferation activity of B16 cells. U DHEE-E 25% DHEE-E 50% DHEE-E 75% and DHEE-E 100% 5 elution fractions to further explore DHEE-E U DHEE-E 25% DHEE-E 50% DHEE-E 75% and DHEE-E 100%Effects of different administration times and dosages of the five elution fractions on B16 cell proliferation. Figure 4 As shown, within the range of 0.05-0.8 mg / mL and the administration time of 24 h, DHEE-E U DHEE-E 25% DHEE-E 50% DHEE-E 75% and DHEE-E 100% All of them have an inhibitory effect on the proliferation of B16 cells, among which DHEE-E 75% DHEE-E 50% and DHEE-E 100% The inhibitory effect on B16 cells was more obvious. 75% The effect on B16 cells was most obvious, with IC50 = 0.18 ± 0.02 mg / mL. The cell survival rate decreased with the increase of the administration concentration, and it was dose-dependent. Within the same administration range, the administration time was 48h, DHEE-E U DHEE-E 25% DHEE-E 50% DHEE-E 75% and DHEE-E 100% All of them have an inhibitory effect on the proliferation of B16 cells, among which DHEE-E 75% DHEE-E 50% DHEE-E 25% and DHEE-E 100% The inhibitory effect on B16 cells was more obvious. 75% The effect on B16 cells is most obvious, with IC50 = 0.08 ± 0.02 mg / mL. The cell survival rate decreases with the increase of the administration concentration and is dose-dependent.
[0049] 4. Effect of CCK-8 assay on the proliferation of A375 cells
[0050] DHEE-E U DHEE-E 25% DHEE-E 50% DHEE-E 75% and DHEE-E 100% Toxicity experiment: Through preliminary screening and verification, DHEE-E 75% The inhibitory effect on B16 cells was the most obvious, and it was concentration- and time-dependent, but it could not fully explain that the drug had an inhibitory effect on melanoma proliferation. Therefore, A375 cells were selected for subsequent research to determine the effects of different dosing concentrations and dosing times on A375 cell proliferation. Figure 5As shown, within the range of 0.05-0.8 mg / mL, DHEE-E U DHEE-E 25% DHEE-E 50% DHEE-E 75% and DHEE-E 100% The five elution fractions all had an inhibitory effect on the proliferation of A375 cells, among which DHEE-E 75% DHEE-E 50% and DHEE-E 100% The inhibitory effect on A375 cells was more obvious. 75% The effect on A375 cells was most obvious, IC50 = 0.32 ± 0.06 mg / mL, and the cell survival rate decreased with the increase of the administration concentration, and it was dose-dependent. Within the same administration range, the administration time was 48h, DHEE-E U DHEE-E 25% DHEE-E 50% DHEE-E 75% and DHEE-E 100% All of them had an inhibitory effect on the proliferation of A375 cells, among which DHEE-E 75% DHEE-E 50% and DHEE-E 100% The inhibitory effect on A375 cells was more obvious. 75% The effect on A375 cells was the most obvious, with IC50 = 0.19 ± 0.02 mg / mL. The cell survival rate decreased with the increase of the administration concentration, and it was dose-dependent. In summary, the administration time and dosage had a certain effect on the survival rate of A375 cells. Therefore, in subsequent experiments, we will verify the effect of DHEE-E on the survival rate of A375 cells through in vitro and in vivo experiments. 75% Effects on the proliferation activity of B16 cells.
[0051] 5. DHEE-E 75% Effects on B16 cell morphology
[0052] The results are as follows Figure 6As shown in the figure, the B16 cells in the normal group were long spindle or fusiform, and the adhesion state was good, with no dead cells or a small number of dead cells. 24 hours after administration, when the drug concentration reached 0.2 mg / mL, the cells were placed under a microscope for observation, and a small number of live cells began to die, and the cells shrank and rounded; when the drug concentration reached 0.4 mg / mL, the number of B16 cells decreased significantly, most of the cells shrank and rounded, and the cell morphology changed from the long spindle before administration to vacuoles, and a large number of cell fragments appeared, and there were almost no adherent cells. 48 hours after administration, when the drug concentration reached 0.1 mg / mL, a small number of cells died, and some cells shrank or even rounded; when the drug concentration reached 0.2 mg / mL, the number of B16 cells decreased significantly, most of the cells shrank and rounded, and the cell morphology changed from the long spindle before administration to vacuoles, and a large number of cell fragments appeared, and there were almost no adherent cells.
[0053] 6. DHEE-E 75% Effects on live-dead staining of B16 cells
[0054] like Figure 7 As shown in the figure, the live-dead staining results showed that compared with the blank group, DHEE-E 75% After 24h of treatment, the number of live cells in the 0mg / mL Calcein-AM group decreased compared with the drug-treated group, while the number of dead cells in the 0mg / mL PI group increased compared with the drug-treated group, and both Calcein-AM and PI showed dose-dependency.
[0055] 7. DHEE-E 75% Effects on apoptosis and cell cycle of B16 cells
[0056] like Figure 8 As shown in the figure, the results of the cell apoptosis experiment showed that within the dosage range of 0.1mg / mL to 0.4mg / mL, cells were exposed to different concentrations of DHEE-E. 75% After 24 hours of treatment, the apoptosis rate of B16 cells increased in a dose-dependent manner. The apoptosis rate of 0 mg / mL cells was 5.51±0.41%, the apoptosis rate of 0.1 mg / mL cells was 26.77±1.24%, the apoptosis rate of 0.2 mg / mL cells was 43.71±0.71%, and when the drug concentration was 0.4 mg / mL, the apoptosis rate of B16 cells was 62.81±0.96%; the cell cycle results showed that compared with the blank group, DHEE-E 75%After 24 hours of treatment, the percentage of cells in the G0 / G1 phase was 82.23±1.27% at 0mg / mL, 65.95±1.20% at 0.1mg / mL, 45.55±0.24% at 0.2mg / mL, and 31.47±0.71% at 0.4mg / mL. With the increase of the drug concentration, the percentage of cells in the G0 / G1 phase showed a downward trend; the percentage of cells in the S phase was 10.47±1.46% at 0mg / mL, 24.03±1.57% at 0.1mg / mL, and 41.81±0. 43%, 0.4mg / mL accounted for 51.32±1.20%, S phase, with the increase of drug concentration, the percentage of S phase cells showed an upward trend; G2 / M phase 0mg / mL accounted for 7.31±0.81%, 0.1mg / mL accounted for 10.02±0.43%, 0.2mg / mL accounted for 12.64±0.61%, 0.4mg / mL accounted for 17.20±0.49%, G2 / M phase with the increase of drug concentration, the percentage of G2 / M phase cells showed an upward trend; Through the experimental results of cell cycle, it can be obtained that DHEE-E 75% It can induce B16 cell cycle arrest at the S phase. The results of cell apoptosis and cell experiments show that DHEE-E 75% It can significantly inhibit the proliferation of B16 cells and induce their apoptosis in vitro.
[0057] 8. DHEE-E 75% Expression of apoptosis-related proteins in B16 cells
[0058] like Fig. 9 As shown. Related literature reports that cell apoptosis is regulated by multiple genes and is a process in which multiple inhibitory factors and promoting factors work together. Bcl-2 and Bax are particularly important apoptosis-related proteins. Bcl-2 is a protein that inhibits cell apoptosis, and Bax is a protein that promotes cell apoptosis. In the experiment, Western blot results showed that DHEE-E 75% It can reduce the expression of Bcl-2 and promote the expression of Bax in a dose-dependent manner, indicating that DHEE-E 75% It may promote the apoptosis of B16 cells by regulating the expression of apoptosis-related proteins.
[0059] 9. DHEE-E 75% In vivo antitumor effect
[0060] like Fig.10 As shown in A, B, and C in Figure 1, compared with the Model group, the body weight of mice in the drug-treated group did not change significantly, but the tumor growth was significantly inhibited, and the tumor volume was significantly reduced. The tumor inhibition rate was proportional to the dosage, and the tumor inhibition rates of the L, M, and H groups were 63.09%, 64.40%, and 74.67%, respectively. Fig.10 As shown in D, E, and F, the spleen weight of the H group was reduced compared with that of the Model group, but there was no significant difference, indicating that the H group may inhibit important immune organs such as the spleen of mice while inhibiting tumors. The spleen weights of the other groups showed no significant changes compared with the Model group.
[0061] In summary, DHEE was obtained by alcohol extraction. In the toxicity experiment, DHEE had a better inhibitory effect on the proliferation of B16 cells. The results of UPLC-Q-TOF / MS showed that 614 components were detected in DHEE, of which 72 components were identified. At the same time, DHEE was extracted by organic solvent extraction to obtain three components: DHEE-E, DHEE-N and DHEE-U. In the toxicity experiment, DHEE-E had a strong inhibitory effect on the proliferation of B16 cells. DHEE-E was then eluted by column chromatography to obtain DHEE-E. U DHEE-E 25% DHEE-E 50% DHEE-E 75% and DHEE-E 100% Among the five components, DHEE-E 75% The best inhibitory activity on B16 cells was observed; UPLC-Q-TOF / MS results showed that DHEE-E 75% 390 compounds were detected in 75% 42 ingredients were identified. Among them, 26 ingredients such as Isorhamnetin, Isoquercitrin, and Baicalein were DHEE and DHEE-E 75% The common components provide a certain material basis for the subsequent screening of anti-tumor active drugs. Through in vitro experiments such as cell live-death staining and cell morphology, it was found that DHEE-E 75% It has a certain inhibitory effect on the proliferation of B16 cells. The results of in vivo studies show that DHEE-E 75% In the mouse melanoma model, it can effectively inhibit tumor growth and has no toxic side effects on various tissues and organs. In summary, Huoshan Dendrobium showed significant anti-tumor activity both in vivo and in vitro. DHEE and DHEE-E 75% A total of 26 components may be related to its anti-tumor mechanism, which explains the anti-tumor efficacy basis of Huoshan Dendrobium and provides a certain theoretical basis for further screening of anti-tumor active drugs.
Claims
1. A method for extracting a Dendrobium huoshanense extract, characterized in that: The method includes: The crushed Dendrobium huoshanense was immersed in an ethanol solution for heating extraction to obtain the Dendrobium huoshanense ethanol extract DHEE; The ethanol extract of Dendrobium huoshanense DHEE is extracted with ethyl acetate, and the ethyl acetate phase obtained after the extraction is concentrated under reduced pressure to obtain a DHEE-E component; The DHEE-E extract was subjected to column chromatography and eluted with an ethanol solution. The obtained eluate was concentrated under reduced pressure to obtain the Huoshan Dendrobium officinale extract.
2. The method for extracting the Dendrobium huoshanense extract according to claim 1, characterized in that: During the heating extraction, the crushed Huoshan Dendrobium is immersed in a 70-80% ethanol solution at a material-liquid ratio of 1:10-1:40 (w:v).
3. The method for extracting the Dendrobium huoshanense extract according to claim 1, characterized in that: The temperature during heating extraction is 70-85°C and the extraction time is 2-4h.
4. The method for extracting the Huoshan Dendrobium officinale extract according to claim 1, characterized in that: The ethyl acetate extraction process comprises: taking DHEE freeze-dried powder, fully dissolving it with ethyl acetate, placing it in a separatory funnel, and adding 0.5-2 times the volume of water.
5. The method for extracting the Huoshan Dendrobium officinale extract according to claim 1, characterized in that: When eluting by column chromatography, use ethanol solution for 8 to 10 column volumes, and collect the eluate according to 1 to 2 column volumes.
6. The method for extracting the Huoshan Dendrobium extract according to claim 1, characterized in that: The concentration of the ethanol solution used for column chromatography elution is 50% to 100%.
7. The method for extracting the Dendrobium huoshanense extract according to claim 1, characterized in that: The concentration of the ethanol solution used for column chromatography elution is 50% to 75%.
8. A Huoshan Dendrobium extract, characterized in that: The extract is obtained by extraction using any one of the extraction methods described in claims 1-7.
9. Use of the Dendrobium huoshanense extract according to claim 8 in the preparation of anti-tumor drugs.
10. The use of the Huoshan Dendrobium officinale extract in the preparation of anti-tumor drugs according to claim 9, characterized in that: The tumor is melanoma.
Citation Information
Patent Citations
Dendrobium huoshanense refined polysaccharide having anti-tumor effects and preparation method thereof
CN108912236A
Dendrobium huoshanense and ginseng oral liquid and preparation process and application thereof
CN113080454A
Phenolic acid compound Reusiusines H as well as preparation method and application thereof
CN116874374A
Bibenzyl compound as well as preparation method and application thereof
CN117945865A
Skin-protection composition containing dendrobium-based ingredients
US20170057906A1
Cited By
Alkaloid as well as preparation method and application thereof
CN120365290A
An alkaloid, its preparation method and application
CN120365290B
